Diabetes Severity Does Not Predict Complications
Common diabetic complications cannot be predicted by the severity of a patient's diabetes, a new study has found. The severity of diabetes does not appear to be linked with the number of complications the patient may have. Findings were presented to the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.
Common complications to diabetes include blood pressure issues, vision problems, kidney complications, and oral health issues. Other complications can include erectile dysfunction, circulation problems, and neurological issues.
No "meaningful association between the severity of diabetes and the number of associated conditions."
The study, conducted at the Western University of Health Sciences in Pomona, California, was led by Adeba Mohammad. Dr. Mohammad presented the findings at the World Congress.
The study looked at data on 160 men and women with type 2 diabetes. Nine possible conditions, often related to diabetes, were considered. Most concerned with heart disease risks, eyesight problems, kidney disease, and dental health. The conditions were rated in severity using a modified health scorecard in the Diabetes Cross-Disciplinary Index.
The researchers found that there was no significant increase in the number of related conditions to diabetes when the severity of the person's diabetes was used as a measure. Most diabetic patients have an average of two chronic health conditions related to their type 2 diagnosis.
The research also resulted in a new "scorecard" for use in illustrating to patients their risk factors for various diabetes-related illnesses. The "DXDI" scorecard is in use at the Western Diabetes Institute at the Western University of Health Sciences with positive patient feedback thus far.
The modified index is colorized and charted with symbols for various conditions or activities on the horizontal axis and with severity scores (1-5) on the vertical. The fields created are then filled in to include risk factors and other information for the patient.
The usefulness of the DXDI scorecard tool as an educational device for patients is being tested.
Source: endocrineweb.com